Anavex Life Sciences Corp (AVXL)

[falconer66a]

"Right-to-Try" a good idea. But doesn't work.

Would be interesting to know if AVXL is engaged in supporting "Right to Try" initiatives.

This topic was discussed at length, in 2018 when the Right to Try rules were enacted. For a number of reasons Anavex will not be participating in any Right to Try initiatives involving blarcamesine for any CNS disease.

First, the patient taking the unapproved drug would have to buy and acquire it. Lots of issues just with that, regarding price, etc. Anavex doesn't choose to make blarcamesine pills available to the public in any way; lots of issues with that. What dosage would be sold? Who would do the dosage titrations, if they were required?

If a patient or administrating medical professional got things wrong and the patient suffered from an overdose, there could be all sorts of legal liabilities, for any and all parties.

The intent of the "Right to Try" law was laudable. But, in reality, it has proven unworkable. Has anyone heard of any new, unapproved drug being successfully used for anything? Too many potential problems for all three parties, the patients, their physicians, and the drug manufacturer.